Direkt zum Inhalt
Merck
  • Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.

Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.

American journal of kidney diseases : the official journal of the National Kidney Foundation (2008-11-26)
Sankar D Navaneethan, Sonal Singh, Suresh Appasamy, Richard E Wing, Ashwini R Sehgal
ZUSAMMENFASSUNG

Optimal hydration measures to prevent contrast-induced nephropathy are controversial. We conducted a systematic review and meta-analysis using the MEDLINE database (1966 to January 2008), EMBASE (January 2008), and abstracts from conference proceedings. Adult patients undergoing contrast procedures. Randomized controlled trials comparing intravenous hydration with sodium bicarbonate with hydration with intravenous normal saline for prevention of contrast-induced nephropathy. Hydration with intravenous sodium bicarbonate with or without N-acetylcysteine versus hydration with normal saline with or without N-acetylcysteine. Contrast-induced nephropathy, need for renal replacement therapy, and worsening of heart failure. Twelve trials (1,854 participants) were included. Sodium bicarbonate significantly decreased the risk of contrast-induced nephropathy (12 trials, 1,652 patients; odds ratio [OR], 0.46; 95% confidence interval [CI], 0.26 to 0.82; I2 = 55.9%) without a significant difference in need for renal replacement therapy (9 trials, 1,215 patients; OR, 0.50; 95% CI, 0.16 to 1.53; I2 = 0%), in-hospital mortality (11 trials, 1,640 patients; OR, 0.51; 95% CI, 0.15 to 1.69), or congestive heart failure compared with controls. Similar results were seen for the risk of contrast-induced nephropathy when sodium bicarbonate was compared with normal saline alone (OR, 0.39; 95% CI, 0.20 to 0.77), but not when sodium bicarbonate/N-acetylcysteine combination was compared with N-acetylcysteine/normal saline combination (OR, 0.68; 95% CI, 0.34 to 1.37). A subgroup analysis limited to published trials showed similar results (OR, 0.26; 95% CI, 0.10 to 0.64; I2 = 63.3%), whereas unpublished studies showed a nonsignificant decrease (OR, 0.85; 95% CI, 0.46 to 1.57; I2 = 25.9%) in risk of contrast-induced nephropathy. Publication bias and heterogeneity. Hydration with sodium bicarbonate decreases the incidence of contrast-induced nephropathy in comparison to hydration with normal saline without a significant difference in need for renal replacement therapy and in-hospital mortality. Larger studies analyzing patient-centered outcomes are needed.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Natriumbicarbonat, ACS reagent, ≥99.7%
Sigma-Aldrich
Natriumbicarbonat, powder, BioReagent, Molecular Biology, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
Natriumbicarbonat, ReagentPlus®, ≥99.5%, powder
Sigma-Aldrich
Natriumbicarbonat -Lösung, solution (7.5%), sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
Natriumbicarbonat, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E500, 99.0-100.5%, powder
Sigma-Aldrich
Natriumbicarbonat, BioXtra, 99.5-100.5%
USP
Natriumbicarbonat, United States Pharmacopeia (USP) Reference Standard
Supelco
Natriumbicarbonat-Konzentrat, 0.1 M NaHCO3 in water, eluent concentrate for IC
Sigma-Aldrich
Natriumbicarbonat, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Natriumbicarbonat, −40-+140 mesh, ≥95%
Sigma-Aldrich
Natriumbicarbonat, tested according to Ph. Eur.
Sigma-Aldrich
Natriumbicarbonat-12C, 13C-depleted, 99.9 atom % 12C